Kalin Harvey

Co-Founder and CTO

Data updated

Papers

5 publications

Trials

0 clinical trials

Links

Research Footprint

Kalin Harvey appears in 5 tracked papers (2021–2026), most studied alongside Psilocybin and Placebo, across Anxiety Disorders, Depressive Disorders and Palliative & End-of-Life Distress.

Most-cited paper: Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers (75 citations).

Frequent co-authors: Susanna Myers, Mendel Kaelen and Kim Kuypers.

Background & Research

Kalin Harvey is a technology leader and co-founder/CTO of Quantified Citizen. He is also listed as cofounder and director of the Psychedelic Data Society, which supports evidence-based data collection for psychedelic practices and drug policy reform. His author record shows contributions to psilocybin microdosing studies and recent psilocybin therapy papers.

Key Impact

Kalin Harvey is a psychedelic research and harm-reduction entrepreneur whose work helps enable real-world data collection and publishing in psychedelic science.

5

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

7 collaborators· click a node to visit their profile

Full network →

Affiliations

Institutions, companies, and organisations Kalin Harvey is associated with.